Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of GSK Biological's dTpa-IPV Booster Vaccine in Children and Adolescents, 5 Years After Previous dTpa-IPV Boosting.

NCT00635128 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00635128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00635128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of GSK Biological's dTpa-IPV Booster Vaccine in Children and Adolescents, 5 Years After Previous dTpa-IPV Boosting.
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2008
Completion date
July 8, 2008
Enrollment
415 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, poliomyelitis, tetanus